Bank Of Hawaii Edwards Lifesciences Corp Transaction History

Bank Of Hawaii

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$82.37 - $107.29 $9,307 - $12,123	113 Added 1.3%	8,789 $726,000
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $750,474 - $1.11 Million	8,676 New	8,676 $825,000
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $559,356 - $727,938	-8,325 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $247,422 - $330,885	4,300 Added 106.83%	8,325 $575,000
Q1 2020 May 13, 2020	BUY	$52.41 - $81.0 $69,705 - $107,730	1,330 Added 49.35%	4,025 $759,000
Q3 2019 Nov 15, 2019	BUY	$61.55 - $75.43 $165,877 - $203,283	2,695 New	2,695 $593,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Bank Of Hawaii, based on Form 13F filings with the SEC.

Stay updated on Bank Of Hawaii with notifications on news.